Wright Medical — Merger or Acquisition (October 2014)
17 slides from Wright Medical's merger presentation, Oct 28, 2014
Slide 1: Employee Communication Meetings
Filed by Tornier N.V. (SEC File No.: 001-35065) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Wright Medical Group, Inc. SEC File No.: 001-35823 Employee Communication Meetings
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements.These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “proj
Slide 3: Important Additional Information And Where To Find It
Important Additional Information And Where To Find It In connection with the proposed merger, Tornier plans to file with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 that will include a joint proxy statement of Wright and Tornier that also constitutes a pros
Slide 4: Agenda
Agenda • Yesterday’s Announcements • Who Is Wright? • Why this combination? • What happens after today? • How are we planning for the future? • Leadership’s commitment to you • Conclusion & Summary • Q&A Confidential | Page 4
Slide 5: Yesterday's Announcement to Combine
Yesterday’s Announcement to Combine The combination will generate long-term value for our customers, our employees and our shareholders. Creates a Premier High-Growth Extremities-Biologics Company with Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerat
Slide 6: Important Notes on the Announcement to Combine
Important Notes on the Announcement to Combine Excitement about Wright’s and Tornier’s leaders are thrilled about this once in a life time the Deal opportunity and the future of combined organization Thecombinedcompanywill continueto be known asWrightMedicaland Familiar Name will be led by Bob Palmi
Slide 7: Corporate Footprint
Corporate Footprint • No immediate plans to consolidate facilities, however, Executive Leadership to be co-located in Memphis as the U.S. HQ for our combined business Corporate • U.S. headquarters for Upper Extremity business will leverage Footprint Tornier’s existing footprint • U.S. headquarters f
Slide 8: Wright at a Glance
Wright at a Glance Company Summary Recent Strategic Initiatives • Extremities-Biologics company with leadership position • Completed transformation to high growth Extremities- in in Lower Extremities -- foot & ankle Biologics pure play through successful divestiture of • NASDAQ: WMGI www.wmt.com Ort
Slide 9: Compelling Strategic Rationale
Compelling Strategic Rationale • Combines Wright’s leadership in the lower extremities market with Tornier’s leadership in upper and lower extremities to create a premier high-growth global Extremities-Biologics company! • Creates a mid-sized growth company uniquely positioned with leading technolog
Slide 10: Natural, Highly Complementary Fit of Both Businesses
Natural, Highly Complementary Fit of Both Businesses • We have complementary product offerings in the extremities segment, providing opportunities for growth beyond what we could achieve as individual companies • We both share consistent and complementary approaches to the market • We are committed
Slide 11: We speak a common language
We speak a common language Confidential | Page 11
Slide 12: We can achieve more as one company!
We can achieve more as one company! EMPLOYEES will benefit from being part of a larger, dynamic organization that brings together two leading companies and offers enhanced opportunities for career growth Combined products, sales and distribution talent, medical education and relationships expand the
Slide 13: What does this mean for employees TODAY?
What does this mean for employees TODAY? • Close in 2015: Deal is expected to close in the first half of 2015 and will require regulatory and shareholder approvals • Business as Usual: Please remember Customer Service is our Number One Priority and it is imperative that we continue to execute on ope
Slide 14: How are we planning for the integration after close?
How are we planning for the integration after close? • Significant Resources are Dedicated to the Combination and over the next days, weeks and months, we aim to: Identify best practices from both organizations that leverage our strengths, maximize growth and deliver best-in-class service Reposition
Slide 15: Commitment to open & transparent communication
Commitment to open & transparent communication • There will be a future opportunity to meet with Tornier and new Wright Medical leadership • We will provide ongoing, frequent and timely updates: – In-person, department meetings – Written communications – Management team is dedicated to obtaining ans
Slide 16: A bright & exciting future as new Wright Medical!
A bright & exciting future as new Wright Medical! Premier High-Growth Accelerated Growth Significant Scale and Extremities-Biologics Opportunities Scope Company Better Serves Customers Increases Employee Development Opportunities Satisfies Shareholders | Confidential | Page 16
Slide 17: Q&A
Q&A
Wright Medical Group — Merger or Acquisition (October 2014) on 6ix